BridgeMD
Tests treatment safety and results for Parkinson's Disease
Official title Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
ClinicalTrials.gov ID: NCT06028529
What this study is testing
- What it's testing
- Physical therapy approaches for balance and walking deficits in Parkinson's disease (PD) have limited effectiveness, with mostly short-lasting benefits. An exoskeleton is a device that straps to the legs and provides a passive force to assist people to better ambulate.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- PD confirmed by a PADRECC movement disorder specialist using UK Brain Bank Criteria
- Modified H\&Y stage II-V
- Veteran
- Able to attend visits at the Richmond VA Medical Center
You likely can't join if
- neurological, musculoskeletal, or other disorders unrelated to PD contributing to impairment of stance, gait, balance or coordination
- severe CHF, COPD, or those requiring nasal canula O2
- history of implantable cardiac device or ablative surgery
- moderately-severe to severe cognitive impairment / dementia (Montreal Cognitive Assessment \< 17/30)
- symptomatic orthostatic hypotension with exertion
- feeding tube or associated port placement (PEG/J-PEG)
See the full eligibility criteria
- PD confirmed by a PADRECC movement disorder specialist using UK Brain Bank Criteria
- Modified H\&Y stage II-V
- Veteran
- Able to attend visits at the Richmond VA Medical Center
- neurological, musculoskeletal, or other disorders unrelated to PD contributing to impairment of stance, gait, balance or coordination
- severe CHF, COPD, or those requiring nasal canula O2
- history of implantable cardiac device or ablative surgery
- moderately-severe to severe cognitive impairment / dementia (Montreal Cognitive Assessment \< 17/30)
- symptomatic orthostatic hypotension with exertion
- feeding tube or associated port placement (PEG/J-PEG)
- body height less than 5'1" or greater than 6'3"
- body weight greater than 250 pounds
- amputation of any portion of the lower limbs
- osteoporosis as defined by DEXA Scan T score \< -2.5
- failure to meet B-Temia-established hip and knee flexion and extension manual muscle test (MMT) prerequisite screening parameters, which assure that individuals can adequately engage and walk against the resistive...
- inability to complete 20 minutes of walking with the exoskeleton (over a maximum period of one hour) at the initial screening/testing session
The study team makes the final eligibility decision.
Where it's taking place
- Richmond, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Richmond, Virginia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.